Design Principles for Economic Evaluations in Pharmacy
暂无分享,去创建一个
[1] A. Serrano-Blanco,et al. Cost-Effectiveness of a Community Pharmacist Intervention in Patients with Depression: A Randomized Controlled Trial (PRODEFAR Study) , 2009, PloS one.
[2] C. Ukwe,et al. Cost-Utility Analysis of Pharmaceutical Care Intervention Versus Usual Care in Management of Nigerian Patients with Type 2 Diabetes. , 2013, Value in health regional issues.
[3] S. Marušić,et al. Economic evaluation of a pharmaceutical care program for elderly diabetic and hypertensive patients in primary health care: a 36-month randomized controlled clinical trial. , 2015, Journal of managed care & specialty pharmacy.
[4] G. Barton,et al. An evaluation of a multi‐site community pharmacy–based chronic obstructive pulmonary disease support service , 2015, The International journal of pharmacy practice.
[5] David Moher,et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[6] O. Freitas,et al. Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. , 2011, Arquivos brasileiros de endocrinologia e metabologia.
[7] M. Sculpher,et al. Cost-effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings. , 2010, The British journal of general practice : the journal of the Royal College of General Practitioners.
[8] P. Mazzola,et al. Cost analysis of pharmaceutical care provided to HIV-infected patients: an ambispective controlled study , 2015, DARU Journal of Pharmaceutical Sciences.
[9] Francisco Jódar-Sánchez,et al. Cost-Utility Analysis of a Medication Review with Follow-Up Service for Older Adults with Polypharmacy in Community Pharmacies in Spain: The conSIGUE Program , 2015, PharmacoEconomics.
[10] Martin Eden,et al. Cost Effectiveness of a Pharmacist-Led Information Technology Intervention for Reducing Rates of Clinically Important Errors in Medicines Management in General Practices (PINCER) , 2014, PharmacoEconomics.
[11] Mark Sculpher,et al. Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[12] G. Crealey,et al. Cost-utility analysis of a pharmacy-led self-management programme for patients with COPD , 2011, International Journal of Clinical Pharmacy.
[13] B. Claus,et al. Epidemiology and cost analysis of pharmacist interventions at Ghent University Hospital , 2012, International Journal of Clinical Pharmacy.
[14] S. Wordsworth,et al. Cost-minimisation analysis versus cost-effectiveness analysis, revisited. , 2013, Health economics.
[15] T. Miller,et al. Cost-Effectiveness of Reducing Glycaemic Episodes Through Community Pharmacy Management of Patients with Type 2 Diabetes Mellitus , 2014, The Journal of Primary Prevention.
[16] Andrea Manca,et al. ‘Lost in Translation’ , 2012, PharmacoEconomics.
[17] M. le Vaillant,et al. Cost-Effectiveness of a Community Pharmacist-Led Sleep Apnea Screening Program – A Markov Model , 2013, PloS one.
[18] A. Briggs,et al. One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services. , 2011, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.